Literature DB >> 28181383

Slowly on, Slowly off: Bisubstrate-Analogue Conjugates of 5-Iodotubercidin and Histone H3 Peptide Targeting Protein Kinase Haspin.

Katrin Kestav1, Kaido Viht1, Anton Konovalov1, Erki Enkvist1, Asko Uri1, Darja Lavogina1.   

Abstract

The atypical protein kinase haspin is a key player in mitosis by catalysing the phosphorylation of Thr3 in histone H3, and thus ensuring the normal function of the chromosomal passenger complex. Here, we report the development of bisubstrate-analogue inhibitors targeting haspin. The compounds were constructed by linking 5-iodotubercidin to the N terminus of histone H3 peptide. The new conjugates show high affinity (sub-nanomolar KD ) towards haspin as well as slow kinetics of association and dissociation (residence time of several hours). This reflects a unique binding mode and translated into improved selectivity. The latter was confirmed in a biochemical binding/displacement assay with a panel of ten protein kinases, in a thermal shift assay with off-targets of 5-iodotubercidin (adenosine kinase and the Cdc2-like kinase family) and in assay with spiked HeLa cell lysate.
© 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  5-iodotubercidin; association/dissociation kinetics; haspin; histone H3; inhibitors; iodine

Mesh:

Substances:

Year:  2017        PMID: 28181383     DOI: 10.1002/cbic.201600697

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  2 in total

1.  Anti-Melanoma Activities of Haspin Inhibitor CHR-6494 Deployed as a Single Agent or in a Synergistic Combination with MEK Inhibitor.

Authors:  Lili Han; Peiling Wang; Yang Sun; Sijing Liu; Jun Dai
Journal:  J Cancer       Date:  2017-08-25       Impact factor: 4.207

2.  Women with polycystic ovary syndrome present with altered endometrial expression of stanniocalcin-1†.

Authors:  Masuma Khatun; Riikka K Arffman; Darja Lavogina; Marika Kangasniemi; Johanna Laru; Anne Ahtikoski; Siri Lehtonen; Mariana Paulson; Angelica Lindén Hirschberg; Andres Salumets; Leif C Andersson; Terhi T Piltonen
Journal:  Biol Reprod       Date:  2020-02-14       Impact factor: 4.285

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.